GerardCBlobeMD

Gastrointestinal Cancer

Professor of Medicine, Professor of Pharmacology and Cancer Biology, Duke University

Dr. Blobe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Gerard Blobe is a highly accomplished Oncologist based in Durham, NC, with a subspeciality in Gastrointestinal Cancer. He completed his fellowship in Hematology and Medical Oncology at institutions including Brigham and Women's Hospital, Massachusetts General Hospital, and Dana-Farber Cancer Institute. Dr. Blobe is currently the Associate Director of Training and Education and also holds a Professor position at Duke University Hospital. He brings expertise in treating pancreatic cancer, metastatic colon cancer, and has significant work in biomedical research, gastrointestinal oncology, and general medical oncology. Dr. Blobe has also contributed numerous publications, which have been cited multiple times in scientific journals. He has participated in clinical trials focusing on gastrointestinal cancer treatment and been honored repeatedly as one of America's Top Doctors by Castle Connolly. He was elected a member of The American Society for Clinical Investigation in 2008.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1997 - 2000
Brigham and Women's HospitalResidency, Internal Medicine, 1995 - 1997
Duke University School of MedicineClass of 1995

PubMed

7 citations
NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.
Swati Sharma, Marcelo Ehrlich, Manqi Zhang, Gerard C Blobe, Yoav I Henis
Communications Biology. 2024-01-19
Assessing the utility of molecular diagnostic classification for cancers of unknown primary.
Elle C Moore, Gerard C Blobe, Nicholas C DeVito, Brent A Hanks, Michael R Harrison
Cancer Medicine. 2023-10-01
13 citations
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer
John H. Strickler, Christel Rushing, Hope E. Uronis, Michael A. Morse, Donna Niedzwiecki
The Oncologist. 2021-06-01

Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory BoardMarch 7th, 2022
Recipients of AACR Research Funding & Fellowships 1993–2017September 8th, 2017

Duke PRIME Cancer Research ProgramDUKE UNIVERSITY2023–2028
Duke PRIME Cancer Research ProgramDUKE UNIVERSITY2023–2028
Duke PRIME Cancer Research ProgramDUKE UNIVERSITY2023–2028
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education ProgramDUKE UNIVERSITY2022–2027
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education ProgramDUKE UNIVERSITY2022–2027
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education ProgramDUKE UNIVERSITY2022–2027
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer BiologyDUKE UNIVERSITY2019–2025
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer BiologyDUKE UNIVERSITY2019–2025
Role Of Tbriii In Regulating Motility And InvasionNational Cancer Institute2009–2011
Function Of Tbriii As A BMP Co-Receptor In Human CancerNational Cancer Institute2009–2011
Multispectral Imaging Flow Cytometer CoreNational Center For Research Resources2010
Tbetariii As A Mediator/Regulator Of SignalingNational Cancer Institute2005–2009
ALK-1 And Endoglin Signaling In Endothelial CellsNational Cancer Institute2004–2008
Role Of The Type III Tgf-Beta Receptor In Cancer BiologyNational Cancer Institute2004–2007
Type III Tgf-Beta Receptor In Tgf-Beta SignalingNational Cancer Institute2002–2004